You won’t find test tubes or chemicals at Ampel Biosolutions. Instead, the company uses computers to study huge amounts of medical information – to identify genes responsible for auto-immune, kidney, skin, neurologic and infectious diseases.
Now, a genetic precision medicine test for lupus patients could save lives by predicting heart disease before it happens and providing decision support for prophylactic therapies.
AMPEL BioSolutions has announced that its genetic precision medicine test for lupus patients could predict heart disease and provide decision support for prophylactic therapies.
The CardioGENE lab test identifies inherited genetic markers in blood samples which drive pathways to prevent cardiovascular issues with prophylactic targeted treatment
Ampel Bio-Solutions is working on a blood test that can find out if a person carries traits that may put them at higher risk of developing heart disease.
Researchers have identified shared genetic risk factors for systemic lupus erythematosus and coronary artery disease, according to data published in Cell Reports Medicine.